T
Telomir Pharmaceuticals, Inc. (TELO)
NCM – Real vaqt narxi. Valyuta: USD
1.26
-0.03 (-2.33%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.26
+0.00 (0.40%)
Bozor oldidan: May 13, 2026, 7:00 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.26
-0.03 (-2.33%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.26
+0.00 (0.40%)
Bozor oldidan: May 13, 2026, 7:00 AM EDT
Telomir Pharmaceuticals, Inc., preclinical bosqichdagi biotexnologiya kompaniyasi, qarish va yoshga bog'liq kasalliklarning dastlabki biologik omillarini davolashga qaratilgan kichik molekulali terapevtik vositalarni ishlab chiqishga qaratilgan. Kompaniya Telomir-1, og'iz orqali qabul qilinadigan kichik molekulali metall ion regulyatorini ishlab chiqmoqda, u Vilson kasalligi, 2-toifa diabet, yoshga bog'liq makula degeneratsiyasi (YBMD), onkologiya va epigenetik regulyatsiya, shuningdek, Altsgeymer kasalligi va Progeriya kabi yoshga bog'liq holatlardan himoya qilish uchun mo'ljallangan. Kompaniya ilgari Metallo Therapies Inc. nomi bilan tanilgan va 2022 yil oktyabr oyida Telomir Pharmaceuticals, Inc. deb nomini o'zgartirgan. Telomir Pharmaceuticals, Inc. 2021 yilda ro'yxatga olingan va shtab-kvartirasi Mayami, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Itzchak Angel Ph.D. | Chief Scientific Advisor |
| Mr. Alan Weichselbaum CPA, M.B.A. | Chief Financial Officer |
| Mr. Erez Aminov | Chairman of the Board & CEO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 8-K | form8-k.htm |
| 2026-04-24 | 8-K | form8-k.htm |
| 2026-03-31 | 8-K | form8-k.htm |
| 2026-03-27 | 8-K | form8-k.htm |
| 2026-03-17 | 10-K | form10-k.htm |
| 2026-02-19 | DEFM14A | formdefm14a.htm |
| 2026-02-19 | DEFA14A | formdefa14a.htm |
| 2026-02-17 | 8-K | form8-k.htm |
| 2026-02-05 | PRER14A | formprer14a.htm |
| 2026-01-23 | PRER14A | formprer14a.htm |